Abcam PLC (ABCM)
| Market Cap | 4.18B |
| Revenue (ttm) | 410.62M |
| Net Income (ttm) | 22.34M |
| Shares Out | 236.81M |
| EPS (ttm) | 0.10 |
| PE Ratio | 180.00 |
| Forward PE | 65.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250,698 |
| Open | 17.83 |
| Previous Close | 17.84 |
| Day's Range | 17.50 - 17.87 |
| 52-Week Range | 17.14 - 24.38 |
| Beta | 0.58 |
| Analysts | Buy |
| Price Target | 1,673.17 (+9,385.1%) |
| Earnings Date | n/a |
About ABCM
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; an...
Analyst Forecast
According to 4 analysts, the average rating for Abcam stock is "Buy." The 12-month stock price forecast is 1,673.17, which is an increase of 9,385.09% from the latest price.
News
Alamar Biosciences partners with Abcam to drive understanding of the human proteome
FREMONT, Calif. and CAMBRIDGE, England, Jan. 4, 2022 /PRNewswire/ -- Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of canc...
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
SEATTLE and CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire/ -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying ...
Abcam completes $340m strategic acquisition and expands kit capacity and capability
- Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene, further growing kits and assays portfolio - Supporting the growing demand of the sector and accelerating execution...
4 High Financial Strength Stocks Trading Near Historical Low Price-Book Ratios
According to the Historical Low Price-Book Screen, a Premium feature of GuruFocus, four stocks with high financial strength and are trading near historical low price-book ratios are Landstar System Inc....
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products ...
CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, to...
Abcam To Acquire Supplier BioVision For $340M In Cash
Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a distributor...
Abcam to Acquire BioVision for $340 million
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research tools,...
New Strong Sell Stocks for July 29th
ABCM, CCJ, EBMT, MRTN and NESR have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2021.
Abcam opens new US facility in Boston, MA
CAMBRIDGE, July 13, 2021 /PRNewswire/ -- Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new...
Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients
SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, England, June 22, 2021 /PRNewswire/ -- Today Pionyr Immunotherapeutics, Inc., a company developing first-in-class antibody therapeutics that increase the body'...
2 of the Safest Biotech Stocks You'll Find Today
They provide the infrastructure and sell the tools that biomedical researchers need to make breakthroughs.
Abcam and MEDx extend precision medicine strategic partnership
CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12, 2021 (GLOBE NEWSWIRE) -- Abcam (AIM: ABC; NASDAQ: ABCM), a global innovator in life science reagents and tools, and MEDx Translational Medicine (...
Avacta Announces Distribution Agreement With ABCAM plc
CAMBRIDGE, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to...
5 Companies Trading Below Historical Low Price-Book as of March
Stocks with high business profitability and price-book ratios near 10-year lows
Abcam Wins Industry Awards from CiteAb
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of Resea...
8.3% constant currency revenue growth in H1 as customers gradually return to labs
CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (“Abcam”, the “Group” or the “Company”), a global leader in the supply of life science research tools, to...
Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector
CAMBRIDGE, United Kingdom, March 04, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the expansion of its footprint in China...
Abcam to Report Interim Results on Monday, March 8, 2021
CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report its ...
Abcam to present at the 2021 SVB Leerink Global Healthcare Conference
CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global Hea...
Abingdon Health signs collaboration and co-marketing agreement with Abcam
Abingdon Health signs collaboration and co-marketing agreement with Abcam
Abcam Plc Appointment of Non-Executive Directors
CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam”), a global leader in the supply of life science research tools, is delighted to announce the appo...
Abcam plc: Annual Report, Impact Report and Notice of AGM
CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 14 Se...
Abcam plc: Consultation on 2020 LTIP Awards
CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following consultation wit...